Literature DB >> 32173684

JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease.

Masato Nakamura1, Kazuo Kimura2, Takeshi Kimura3, Masaharu Ishihara4, Fumiyuki Otsuka5, Ken Kozuma6, Masami Kosuge2, Toshiro Shinke7, Yoshihisa Nakagawa8, Masahiro Natsuaki9, Satoshi Yasuda5, Takashi Akasaka10, Shun Kohsaka11, Kazuo Haze12, Atsushi Hirayama13.   

Abstract

Entities:  

Year:  2020        PMID： 32173684     DOI： 10.1253/circj.CJ-19-1109

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  35 in total

Review 1.  Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives.

Authors:  Masahiro Natsuaki; Shinjo Sonoda; Goro Yoshioka; Hiroshi Hongo; Tetsuya Kaneko; Kuninobu Kashiyama; Kensuke Yokoi; Yutaka Hikichi; Koichi Node
Journal:  Cardiovasc Interv Ther       Date:  2022-03-03

2.  Perioperative Safety of Gastrectomy for Patients Receiving Antithrombotic Treatment.

Authors:  Takuya Kudo; Shingo Kanaji; Ryuichiro Sawada; Hitoshi Harada; Naoki Urakawa; Hironobu Goto; Hiroshi Hasegawa; Kimihiro Yamashita; Takeru Matsuda; Taro Oshikiri; Yoshihiro Kakeji
Journal:  Cancer Diagn Progn       Date:  2022-03-03

Review 3.  Optimal Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Focused Review on High Bleeding Risk.

Authors:  Yunosuke Matsuura; Kohei Moribayashi; Koichi Kaikita
Journal:  J Atheroscler Thromb       Date:  2022-08-06       Impact factor: 4.394

4.  Pseudoxanthoma elasticum resulting in acute coronary syndrome.

Authors:  Hiroki Ono; Akira Oshita; Shinji Inaba; Moeko Kawamata; Yasuhisa Nakao; Teruyoshi Uetani; Jun Muto; Takeshi Joko; Hideo Kawakami
Journal:  J Cardiol Cases       Date:  2022-08-16

Review 5.  Antithrombotic therapy after transcatheter aortic valve replacement.

Authors:  Yusuke Kobari; Taku Inohara; Kentaro Hayashida
Journal:  Cardiovasc Interv Ther       Date:  2022-09-17

6.  The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: a systematic review and meta-analysis.

Authors:  Shanshan Xie; Jingjing Chen; Gang Xiong; Juan Li; Jinjin Wan; Ye Liu; Ruilai Xu; Weifang Zhang
Journal:  Eur J Clin Pharmacol       Date:  2021-08-03       Impact factor: 2.953

7.  Coronary artery bypass graft surgery in patients on ticagrelor therapy is not associated with adverse perioperative outcomes.

Authors:  Sammer Diab; Shemy Carasso; Mattan Arazi; Leonid Sternik; Ehud Raanani; Erez Kachel; Liza Grosman-Rimon; Amjad Shalabi; Offer Amir
Journal:  J Cardiothorac Surg       Date:  2021-05-22       Impact factor: 1.637

8.  Duration and clinical outcome of dual antiplatelet therapy after percutaneous coronary intervention: a retrospective cohort study using a medical information database from Japanese hospitals.

Authors:  Hiroyoshi Yokoi; Eisei Oda; Kazuki Kaneko; Kenta Matsubayashi
Journal:  Cardiovasc Interv Ther       Date:  2022-02-09

Review 9.  Platelet Function and Genotype after DES Implantation in East Asian Patients: Rationale and Characteristics of the PTRG-DES Consortium.

Authors:  Ae-Young Her; Young-Hoon Jeong; Byeong-Keuk Kim; Hyung Joon Joo; Kiyuk Chang; Yongwhi Park; Young Bin Song; Sung Gyun Ahn; Jung-Won Suh; Sang Yeup Lee; Jung Rae Cho; Hyo-Soo Kim; Moo Hyun Kim; Do-Sun Lim; Eun-Seok Shin
Journal:  Yonsei Med J       Date:  2022-05       Impact factor: 3.052

10.  Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.

Authors:  Jianan Li; Hong Qiu; Lirong Yan; Tingting Guo; Yong Wang; Yang Li; Jianfeng Zheng; Yida Tang; Bo Xu; Shubin Qiao; Yuejin Yang; Runlin Gao
Journal:  J Atheroscler Thromb       Date:  2020-09-08       Impact factor: 4.928
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.